Blood cancer Clinical Trials in Winston-Salem, NC

As of August 2026, 43 paid clinical trials are recruiting for Blood cancer in Winston-Salem, North Carolina. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

43 clinical trials for Blood cancer

·Clear filters·
Email me when a new blood cancer trial opens in Winston-Salem, NC.

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma
Drug: Belantamab mafodotin
Sites in Winston-Salem, Charlotte +28 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024
Apply to this trial

Conditions in Blood cancer (Winston-Salem, NC)

Acute myeloid leukemia (AML)· 11Multiple myeloma· 10Myelodysplastic syndromes (MDS)· 9Non-Hodgkin lymphoma· 6Myelofibrosis· 5Chronic lymphocytic leukemia (CLL)· 4Hematologic malignancy· 4Leukemia (other)· 3Myeloproliferative neoplasm· 3Diffuse large B-cell lymphoma (DLBCL)· 3Mantle cell lymphoma· 2Small lymphocytic lymphoma· 2Acute lymphoblastic leukemia· 1Hodgkin lymphoma· 1Follicular lymphoma· 1Marginal zone lymphoma· 1